EPISODE · Jan 2, 2026 · 46 MIN
The Playbook Behind Consistent Cannabis Products at Scale ft. Ryan Crandall
from The Dime · host Ryan Crandall, Bryan Fields
Everyone wants their product and brand to be known for consistency .Almost no one is willing to do the difficult work that makes consistency possible.This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lastsHow MariMed engineers consistency across states by centralizing inputs & testing aggressively,What it actually takes to make effects-based products consistent and repeatable Chapters00:00 Introduction to the Cannabis Industry and Edibles03:05 The Evolution of Edibles: From Early Days to Now06:01 Ensuring Consistency Across State Lines09:09 Quality Control and Testing in Edibles12:01 Consumer Education and Brand Trust15:13 MariMed Brand Portfolio and Market Strategy18:06 Role of R&D in Product Development21:00 Future Trends and Innovations in Edibles24:03 Building Relationships with Budtenders and Consumers27:58 Exploring Cannabinoids: THCV and CBG Effects30:06 Understanding Edible Experiences and Consumer Expectations32:00 Responsible Product Development in the Cannabis Industry33:52 Brand Strategy and Market Penetration in New States35:51 Innovative Products: Vibations and Consumer Convenience38:04 Navigating the Hemp Market and Brand Expansion39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis44:02 The Importance of Team and Company CultureGuest Links:https://www.marimedinc.com/https://www.linkedin.com/company/marimed-inc/about/https://www.linkedin.com/in/ryan-crandall-43133b12/https://x.com/MariMed_IncSummaryIn this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube: The Dime📸 Instagram: The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Everyone wants their product and brand to be known for consistency .Almost no one is willing to do the difficult work that makes consistency possible. This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down: Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lasts How MariMed engineers consistency across states by centralizing inputs & testing aggressively, What it actually takes to make effects-based products consistent and repeatable Chapters 00:00 Introduction to the Cannabis Industry and Edibles 03:05 The Evolution of Edibles: From Early Days to Now 06:01 Ensuring Consistency Across State Lines 09:09 Quality Control and Testing in Edibles 12:01 Consumer Education and Brand Trust 15:13 MariMed Brand Portfolio and Market Strategy 18:06 Role of R&D in Product Development 21:00 Future Trends and Innovations in Edibles 24:03 Building Relationships with Budtenders and Consumers 27:58 Exploring Cannabinoids: THCV and CBG Effects 30:06 Understanding Edible Experiences and Consumer Expectations 32:00 Responsible Product Development in the Cannabis Industry 33:52 Brand Strategy and Market Penetration in New States 35:51 Innovative Products: Vibations and Consumer Convenience 38:04 Navigating the Hemp Market and Brand Expansion 39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis 44:02 The Importance of Team and Company Culture Guest Links: https://www.marimedinc.com/ https://www.linkedin.com/company/marimed-inc/about/ https://www.linkedin.com/in/ryan-crandall-43133b12/ https://x.com/MariMed_Inc Summary In this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior. Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/
NOW PLAYING
The Playbook Behind Consistent Cannabis Products at Scale ft. Ryan Crandall
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m